Publications by authors named "Annette Larson"

Claim this Profile
B
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.
Rupali Roy, Andrew M Evens, David Patton, Lillia Gallot, Annette Larson

Leuk Lymphomaยท March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis